Miriam Ladická

Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial

Richard Greil, Petra Obrtlíková, Lukáš Smolej et al. · The Lancet Haematology · 2016 · 46 citations

Medicine, Hematology, Immunology +11

Treatment of Relapsed/Refractory Hodgkin Lymphoma: Real-World Data from the Czech Republic and Slovakia

Zdeněk Král, Jozef Michalka, Heidi Móciková et al. · Journal of Cancer · 2019 · 13 citations · Full text

Medicine, Hematology, Oncology +15

Ibrutinib treatment of mantle cell lymphoma complicated by progressive multifocal leukoencephalopathy

Kristína Mosná, Miriam Ladická, Ľuboš Drgoňa et al. · International Journal of Clinical Pharmacology and Therapeutics · 2020 · 12 citations

Medicine, Hematology, Oncology +12

Rituximab Maintenance after Chemoimmunotherapy Induction in 1st and 2nd Line Improves Progression Free Survival: Planned Interim Analysis of the International Randomized AGMT-CLL8/a Mabtenance Trial

Richard Greil, Petra Obrtlíková, Lukáš Smolej et al. · Blood · 2014 · 11 citations

Medicine, Immunology, Oncology +9

Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL‐8a mabtenance trial

Alexander Egle, Thomas Melchardt, Petra Obrtlíková et al. · Cancer Medicine · 2019 · 10 citations · Full text

Medicine, Oncology, Pharmacotherapy +11